Cambridge Healthtech Institute’s Inaugural
AI and Process Control
19-20 March 2025
Cambridge Healthtech Institute’s inaugural AI and Process Control conference explores the integration of artificial intelligence and advanced technologies in biopharmaceutical manufacturing and process development. The program covers AI, machine learning, and digitalisation applications in cell line engineering, cell culture, downstream processing, gene therapy development, and analytical processes. It examines emerging technologies for process monitoring and control in therapeutic protein production, as well as smart, continuous manufacturing approaches. This conference highlights how digitalisation, modelling, and advanced process control are revolutionising biomanufacturing efficiency and quality.
Coverage will include, but is not limited to:
Gene Therapy: The Role of Digitalisation & ML/ AI in Gene Therapy Development
- Benefits of AI, ML, and bioprocessing 4.0 in gene therapy manufacturing
- Utilising ML/AI in developing novel vectors and capsids
- Advanced process control and modelling in gene therapy
- Digitalisation in gene therapy continuous processing
ML Applications in Cell Line Engineering and CLD
- Cell-line performance prediction
- ML-guided plasmid design
- Recombinant construct design
- Using historical data to predict cell-line manufacturability
New Technologies to Support the Implementation of ML/AI in Analytical Development
- Automated data handling
- Digitised ELNs
- Models to support characterisation and CQA identification for viral vectors
Process Monitoring and Control for Therapeutic Proteins
- Emerging inline sensor and noninvasive measurement technologies for monitoring KPPs
- Realtime process control
- Modelling design space and Critical Process Parameters
Smart, Continuous Manufacturing: Digitalisation, Modelling, and Advanced Process Control
- Enhancing continuous processing through digitalisation
- Implementing Advanced Process Control—technology gaps, implementing soft sensors/digital twin approaches
- Digital, AI, ML, and bioprocessing 4.0 approaches to biomanufacturing
- Process analytics, predictive control, and automation
The deadline for priority consideration is Friday 13 September
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: